Trial Profile
Study of Pharmacokinetic Interaction Between Tipranavir and BILR 355 BS Plus Ritonavir
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs BILR 355 BS (Primary) ; Ritonavir; Tipranavir
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 15 Oct 2014 New trial record